IPP Bureau
Venus Remedies awarded its first incentive of Rs.7.50 crore under PLl scheme
By IPP Bureau - March 07, 2024
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Briefs: Zydus, Advanced Enzyme Technologies, Link Pharma Chem and ANVISA
By IPP Bureau - March 07, 2024
ANVISA issues CGMP to Concord Biotech’s Unit I
Nectar Lifesciences’ suo moto clarification on a news item
By IPP Bureau - March 07, 2024
Nectar Lifesciences has clarified that the company has no relation/connection/ association or link of any nature with the Nectar Herbs and Drugs
Aurobindo Pharma appoints N. Ravikiran as Chief Business Officer
By IPP Bureau - March 07, 2024
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
Dr. Lal PathLabs CEO Bharath Uppilliappan steps down
By IPP Bureau - March 07, 2024
Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO
Amita Sharma redesignated As COO- API at Morepen Lab
By IPP Bureau - March 07, 2024
Sharma joined the Morepen Lab in 2004
Govt supports Alchem Synthon with Rs. 8.6 crore loan assistance for chemical production facility
By IPP Bureau - March 07, 2024
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
Strides receives USFDA approval for Gabapentin Tablets
By IPP Bureau - March 06, 2024
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
Dr. Mandaviya inaugurates Sadhana Nitro Chem’s Para Amino Phenol bulk drug plant
By IPP Bureau - March 06, 2024
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Bayer aims to enhance performance and regain strategic flexibility by 2026
By IPP Bureau - March 06, 2024
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Bayer strengthens pharma portfolio with new cardiology drug acoramidis
By IPP Bureau - March 06, 2024
Acquisition of exclusive commercialization rights for European markets
Healthcare Sector Skill Council organises convocation ceremony of Ayush skilled professionals
By IPP Bureau - March 06, 2024
The Convocation ceremony was organized for students skilled and certified in Ayush
Dr Sheth's launches 'Healthy India Initiative’ with Doctors For You
By IPP Bureau - March 06, 2024
Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers
BlueRock Therapeutics Phase I clinical trial for Parkinson’s disease continues to show positive trends
By IPP Bureau - March 06, 2024
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
Sumitomo Corporation launches new refrigerated ocean transportation service
By IPP Bureau - March 05, 2024
Connecting new production and consumption areas of chilled food by low-carbon transportation services
